Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial

Background. An exploratory subanalysis of the ODIN trial was performed to evaluate the efficacy of darunavir/ritonavir (DRV/r) 800/100 mg OD versus 600/100 mg BID in patients who were NNRTI-experienced but PI-naïve. Methods. ODIN was a phase III, 48-week study comparing DRV/r OD versus BID in 590 tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Geretti, Anna Maria, Moeketsi, Mathe, Demasi, Ralph, van Delft, Yvon, Mohammed, Perry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555450/
https://www.ncbi.nlm.nih.gov/pubmed/26357568
http://dx.doi.org/10.1155/2015/962574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555450/
https://www.ncbi.nlm.nih.gov/pubmed/26357568
http://dx.doi.org/10.1155/2015/962574

Ejemplares similares